Notes Payable (Details Narrative) - Bridge Loan Note [Member] - USD ($) |
Dec. 31, 2022 |
Dec. 31, 2021 |
Nov. 11, 2020 |
---|---|---|---|
MyMD Pharmaceuticals (Florida), Inc [Member] | |||
Short-Term Debt [Line Items] | |||
Advances to affiliate | $ 3,000,000 | $ 3,000,000 | |
Accrued interest | 26,137 | 26,137 | |
Notes payable | $ 3,026,137 | $ 3,026,137 | |
Merger Agreement [Member] | |||
Short-Term Debt [Line Items] | |||
Maximum principal amount | $ 3,000,000 | ||
Interest rate | 5.00% | ||
Merger Agreement [Member] | Event of Default [Member] | |||
Short-Term Debt [Line Items] | |||
Interest rate | 8.00% |
X | ||||||||||
- Definition Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of interest payable on debt, including, but not limited to, trade payables. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|